Citation Impact
1 from Science/Nature 66 standout
Citing Papers
Transforming obesity: The advancement of multi-receptor drugs
2024 Standout
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
2023 Standout
Works of D. Luft being referenced
Long-term changes of body weight and cardiovascular risk factors after weight reduction with group therapy and dexfenfluramine.
1994
Author Peers
| Author | Physiology | CCM | PRM | EDM | Molecular Biology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|---|
| D. Luft | 68 | 15 | 25 | 134 | 112 | 24 | 348 | |
| Jin-Koo Lee | 127 | 18 | 14 | 9 | 188 | 31 | 580 | |
| Murat Yildirim | 4 | 3 | 39 | 11 | 745 | |||
| Madhulika Chandra | 182 | 738 | 59 | 48 | 1059 | 13 | 1.8k | |
| H. B. French | 1 | 16 | 256 | |||||
| O. Ferrer | 1 | 18 | 3 | 27 | 35 | 344 |
All Works
Loading papers...